A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma

NCT06102525 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
43
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Rznomics, Inc.